Your browser doesn't support javascript.
loading
mRNAid, an open-source platform for therapeutic mRNA design and optimization strategies.
Vostrosablin, Nikita; Lim, Shuhui; Gopal, Pooja; Brazdilova, Kveta; Parajuli, Sushmita; Wei, Xiaona; Gromek, Anna; Prihoda, David; Spale, Martin; Muzdalo, Anja; Greig, Jamie; Yeo, Constance; Wardyn, Joanna; Mejzlik, Petr; Henry, Brian; Partridge, Anthony W; Bitton, Danny A.
Afiliação
  • Vostrosablin N; Discovery Informatics, MSD Czech Republic s.r.o., Prague, 150 00, Czech Republic.
  • Lim S; Quantitative Biosciences, MSD Singapore, 138665, Singapore.
  • Gopal P; Quantitative Biosciences, MSD Singapore, 138665, Singapore.
  • Brazdilova K; Discovery Informatics, MSD Czech Republic s.r.o., Prague, 150 00, Czech Republic.
  • Parajuli S; Department of Informatics and Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Prague, 160 00, Czech Republic.
  • Wei X; Discovery Informatics, MSD Czech Republic s.r.o., Prague, 150 00, Czech Republic.
  • Gromek A; Bioinformatics, MSD Singapore, 138665, Singapore.
  • Prihoda D; Discovery Informatics, MSD Czech Republic s.r.o., Prague, 150 00, Czech Republic.
  • Spale M; Discovery Informatics, MSD Czech Republic s.r.o., Prague, 150 00, Czech Republic.
  • Muzdalo A; Discovery Informatics, MSD Czech Republic s.r.o., Prague, 150 00, Czech Republic.
  • Greig J; Discovery Informatics, MSD Czech Republic s.r.o., Prague, 150 00, Czech Republic.
  • Yeo C; Quantitative Biosciences, MSD Singapore, 138665, Singapore.
  • Wardyn J; Quantitative Biosciences, MSD Singapore, 138665, Singapore.
  • Mejzlik P; Quantitative Biosciences, MSD Singapore, 138665, Singapore.
  • Henry B; Discovery Informatics, MSD Czech Republic s.r.o., Prague, 150 00, Czech Republic.
  • Partridge AW; Quantitative Biosciences, MSD Singapore, 138665, Singapore.
  • Bitton DA; Quantitative Biosciences, MSD Singapore, 138665, Singapore.
NAR Genom Bioinform ; 6(1): lqae028, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38482061
ABSTRACT
Recent COVID-19 vaccines unleashed the potential of mRNA-based therapeutics. A common bottleneck across mRNA-based therapeutic approaches is the rapid design of mRNA sequences that are translationally efficient, long-lived and non-immunogenic. Currently, an accessible software tool to aid in the design of such high-quality mRNA is lacking. Here, we present mRNAid, an open-source platform for therapeutic mRNA optimization, design and visualization that offers a variety of optimization strategies for sequence and structural features, allowing one to customize desired properties into their mRNA sequence. We experimentally demonstrate that transcripts optimized by mRNAid have characteristics comparable with commercially available sequences. To encompass additional aspects of mRNA design, we experimentally show that incorporation of certain uridine analogs and untranslated regions can further enhance stability, boost protein output and mitigate undesired immunogenicity effects. Finally, this study provides a roadmap for rational design of therapeutic mRNA transcripts.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NAR Genom Bioinform Ano de publicação: 2024 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NAR Genom Bioinform Ano de publicação: 2024 Tipo de documento: Article País de afiliação: República Tcheca
...